Atlas Trials

Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)

Clinical trial NCT04355429 · UNKNOWN

Trial details

NCT number
NCT04355429
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
PneumoniaCoronavirus InfectionCOVID-19
Start date
2020-05-05
Primary completion
2020-07-01
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.